Cytosorbents Corporation (CTSO)
NASDAQ·Healthcare·Medical - Devices
$0.62
+1.12%
Mkt Cap $50.87M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | $9.78M | $9.23M | -5.58% | -$0.05 | -$0.09 | -80.00% | — | — |
| Q4 2025 Nov 13, 2025 | $9.21M | $9.48M | +2.93% | -$0.06 | -$0.04 | +33.33% | — | — |
| Q3 2025 Aug 7, 2025 | $9.22M | $9.62M | +4.29% | -$0.07 | -$0.05 | +28.57% | — | — |
| Q2 2025 May 14, 2025 | $9.01M | $8.73M | -3.11% | -$0.08 | -$0.06 | +25.00% | — | — |
| Q1 2025 Mar 31, 2025 | $10.09M | $6.52M | -35.33% | -$0.07 | -$0.03 | +57.14% | — | — |
| Q4 2024 Nov 7, 2024 | $9.45M | $8.61M | -8.89% | -$0.07 | -$0.08 | -14.29% | — | — |
| Q3 2024 Aug 13, 2024 | $9.68M | $9.89M | +2.22% | -$0.09 | -$0.08 | +11.11% | — | — |
| Q2 2024 May 9, 2024 | $9.78M | $9.79M | +0.06% | -$0.12 | -$0.12 | +0.00% | — | — |
| Q1 2024 Mar 14, 2024 | $9.28M | $8.67M | -6.59% | -$0.14 | -$0.12 | +14.29% | — | — |
| Q4 2023 Nov 9, 2023 | $9.43M | $7.75M | -17.77% | -$0.12 | -$0.21 | -75.00% | — | — |
| Q3 2023 Aug 1, 2023 | $11.03M | $8.07M | -26.81% | -$0.11 | -$0.14 | -27.27% | — | — |
| Q2 2023 May 2, 2023 | $8.73M | $7.91M | -9.39% | -$0.13 | -$0.17 | -30.77% | — | — |
| Q1 2023 Mar 9, 2023 | $8.72M | $7.64M | -12.36% | -$0.17 | -$0.01 | +94.12% | — | — |
| Q4 2022 Nov 3, 2022 | $8.97M | $6.46M | -27.94% | -$0.16 | -$0.28 | -75.00% | — | — |
| Q3 2022 Aug 2, 2022 | $9.58M | $7.33M | -23.44% | -$0.14 | -$0.25 | -78.57% | — | — |
| Q2 2022 May 3, 2022 | $9.72M | $7.92M | -18.47% | -$0.15 | -$0.21 | -40.00% | — | — |
| Q1 2022 Mar 8, 2022 | $9.68M | $9.70M | +0.17% | -$0.13 | -$0.21 | -61.54% | — | — |
| Q4 2021 Nov 4, 2021 | $11.96M | $8.90M | -25.57% | -$0.12 | -$0.15 | -25.00% | — | — |
| Q3 2021 Aug 3, 2021 | $12.27M | $11.37M | -7.37% | -$0.04 | -$0.11 | -181.04% | — | — |
| Q2 2021 May 4, 2021 | $14.13M | $10.14M | -28.22% | -$0.03 | -$0.10 | -200.03% | — | — |